181 related articles for article (PubMed ID: 16714377)
1. Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.
Ko MS; Lee SJ; Kim JW; Lim JW; Kim SG
Drug Metab Dispos; 2006 Aug; 34(8):1353-60. PubMed ID: 16714377
[TBL] [Abstract][Full Text] [Related]
2. Ceramide, an apoptotic rheostat, inhibits CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 activation: the role in glutathione S-transferase A2 gene repression.
Park IN; Cho IJ; Kim SG
Drug Metab Dispos; 2004 Sep; 32(9):893-7. PubMed ID: 15319326
[TBL] [Abstract][Full Text] [Related]
3. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
4. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
Lee SJ; Kim SG
Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
6. Ceramide negatively regulates glutathione S-transferase gene transactivation via repression of hepatic nuclear factor-1 that is degraded by the ubiquitin proteasome system.
Park IN; Cho IJ; Kim SG
Mol Pharmacol; 2004 Jun; 65(6):1475-84. PubMed ID: 15155840
[TBL] [Abstract][Full Text] [Related]
7. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz.
Kang KW; Cho IJ; Lee CH; Kim SG
J Natl Cancer Inst; 2003 Jan; 95(1):53-66. PubMed ID: 12509401
[TBL] [Abstract][Full Text] [Related]
8. Oxidized metabolites of oltipraz exert cytoprotective effects against arachidonic acid through AMP-activated protein kinase-dependent cellular antioxidant effect and mitochondrial protection.
Kwon YN; Shin SM; Cho IJ; Kim SG
Drug Metab Dispos; 2009 Jun; 37(6):1187-97. PubMed ID: 19299524
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
10. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.
Cho IJ; Sung DK; Kang KW; Kim SG
Arch Pharm Res; 2009 Apr; 32(4):625-35. PubMed ID: 19407981
[TBL] [Abstract][Full Text] [Related]
11. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
McMahon M; Itoh K; Yamamoto M; Chanas SA; Henderson CJ; McLellan LI; Wolf CR; Cavin C; Hayes JD
Cancer Res; 2001 Apr; 61(8):3299-307. PubMed ID: 11309284
[TBL] [Abstract][Full Text] [Related]
12. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
Bae EJ; Kim SG
Mol Pharmacol; 2005 Sep; 68(3):660-9. PubMed ID: 15961673
[TBL] [Abstract][Full Text] [Related]
13. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.
Vollrath V; Wielandt AM; Iruretagoyena M; Chianale J
Biochem J; 2006 May; 395(3):599-609. PubMed ID: 16426233
[TBL] [Abstract][Full Text] [Related]
14. Differential hepatic GSTA2 expression of arylalkyl isothiocyanates in vivo and in vitro: the molecular mechanism of gene induction by phenethyl isothiocyanate.
Gum SI; Cho MK
Mol Nutr Food Res; 2013 Dec; 57(12):2223-32. PubMed ID: 24039128
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant and mitochondrial protective effects of oxidized metabolites of oltipraz.
Choi SH; Kim YM; Lee JM; Kim SG
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):213-24. PubMed ID: 20095791
[TBL] [Abstract][Full Text] [Related]
16. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein.
Higgins LG; Cavin C; Itoh K; Yamamoto M; Hayes JD
Toxicol Appl Pharmacol; 2008 Feb; 226(3):328-37. PubMed ID: 18028974
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
18. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
[TBL] [Abstract][Full Text] [Related]
19. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
[TBL] [Abstract][Full Text] [Related]
20. Cell-based studies reveal differences in glutathione S-transferase induction between oltipraz and tert-butylhydroquinone.
Lamb JG; Franklin MR
J Biochem Mol Toxicol; 2002; 16(4):154-61. PubMed ID: 12242683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
